|
Symbol
|
RMACHV | ACKUTQ | ACLATQ | ACRFTQ | RMBDRV | RMBDNV | ADTRTQ | ADZYTQ | RMAV6V |
|---|---|---|---|---|---|---|---|---|---|
| Nom | Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
ASML Hldg. N.V. / Novo Nordisk AS (B) / SAP SE | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | ASML Hldg. N.V. / Novo Nordisk AS (B) | ASML Hldg. N.V. / Novo Nordisk AS (B) | Adidas AG / LVMH Moet Hennessy Louis Vuitton / Novo Nordisk AS (B) | Alcon / Novo Nordisk AS (B) / Roche PS | ASML Hldg. N.V. / Novo Nordisk AS (B) / Oracle Corp. |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
17.08.2026 | 17.03.2027 | 17.03.2027 | 14.04.2027 | 13.08.2027 | 13.08.2027 | 20.08.2029 | 08.09.2026 | 11.10.2028 |
| Ratio | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
757,40 | 418,32 | 384,58 | 303,835 | 217,13 | 217,13 | 192,27 | 288,429 | 188,34 |
| rendement max. p.a. | 890,53% | - | - | - | 11,09% | 8,95% | 11,35% | 54,48% | 20,05% |
| Demande | 38,100 | 67,55 | 73,97 | 86,32 | 98,40 | 98,50 | 94,72 | 90,04 | 78,90 |
| Offre | 38,900 | - | - | - | 99,20 | 99,30 | 95,52 | 90,84 | 80,10 |